Dr. Reddy's Laboratories arrives at its May 29 earnings release with the same fundamental split that has defined this entire preview cycle — except the short side has just re-escalated sharply.
The borrow market delivered a fresh jolt on Wednesday. Short interest jumped 24.5% in a single session to nearly 19.9 million shares, the largest one-day build of the cycle and the highest absolute level seen across this entire run of previews. That follows a week already up nearly 20%, putting the one-month increase at 33.6%. Availability has recovered to 55.7% from the cycle lows near 31–33% seen last week — loosening meaningfully from the tightest readings — but the jump in shares short means the lending pool is absorbing a fresh wave of demand. Cost to borrow has risen 37.5% over the week to 0.84%, the highest rate of this preview cycle. The ORTEX short score has pushed to 57.3, a new high for the series, up from 55.2 just a week ago.
Options traders are reading none of it. The put/call ratio held at 0.15 on Thursday — essentially unmoved from the 0.14–0.15 range that has anchored options flow since mid-May. That reading is less than half the 20-day average of 0.40, and call demand continues to dominate by a wide margin. The contrast with the PCR readings above 1.10 from early May remains stark. The two camps — aggressive short-side building in the lending market versus persistent call-dominated options flow — have refused to converge across ten days of previews. They remain equally dug in heading into the print.
The broader context adds nuance. The stock has drifted lower, down 3.2% over the past month to $13.52, with a modest 0.4% slip on Thursday. Analyst data is too stale to be actionable — the most recent changes are from mid-2025 at the earliest, and the consensus price target reflects a different listing currency entirely. What is visible on the institutional side is a broad-based holder list anchored by Indian promoters and large domestic asset managers, with BlackRock adding roughly 1.3 million shares as of April 30. The factor score picture flags a strong dividend score (90th percentile) but a weak EPS surprise rank (12th percentile) — the latter consistent with the recent notes describing flat revenue growth and contracted margins.
Today's print is therefore a test of which camp has read the fundamentals more accurately: whether the call-heavy options flow signals genuine confidence in a margin or revenue beat, or whether the accelerating short build — now at its most aggressive point of the entire cycle — reflects better-informed conviction about the difficulty of the print.
See the live data behind this article on ORTEX.
Open RDY on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
